XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	3,320	3,600	11:42

Realtime

Geld

Brief

Zeit

3,320

3,600

11:42

XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024

Das Instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY wird ex Kapitalmassnahme gehandelt am 27.05.2024
The instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY is traded ex capital adjustment on 27.05.2024

Das Instrument 65G SE0009723125 NEXTCELL PHARMA AB EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument 65G SE0009723125 NEXTCELL PHARMA AB EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument LM5 BMG375851174 GASLOG LTD CUM.RED.PREF.A EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument LM5 BMG375851174 GASLOG LTD CUM.RED.PREF.A EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument 2NN NL0010773842 NN GROUP NV EO -,12 EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument 2NN NL0010773842 NN GROUP NV EO -,12 EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument 111A US8293926049 SINTX TECHS INC. DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument 111A US8293926049 SINTX TECHS INC. DL-,01 EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument 1EZ0 FR001400CF13 EUROPLASMA EO -,0002 EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument 1EZ0 FR001400CF13 EUROPLASMA EO -,0002 EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument G9KB GB00BF5H9P87 GREAT P.EST.LS-,152631578 EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument G9KB GB00BF5H9P87 GREAT P.EST.LS-,152631578 EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Das Instrument USZ0 AU0000284366 BPH GLOBAL LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 27.05.2024 und ex Kapitalmassnahme am 28.05.2024
The instrument USZ0 AU0000284366 BPH GLOBAL LTD. EQUITY is traded cum capital adjustment on 27.05.2024 and ex capital adjustment on 28.05.2024

Zeit	Aktuelle Nachrichten
Fr	Seaweed grows for free in the ocean - and BPH Global is using it to extract silver; cobalt
Mi	BPH GLOBAL LTD: Exceptional silver and cobalt assays from seaweed
Mo	BPH GLOBAL LTD: Results of Meeting
So	BPH GLOBAL LTD: Deployment of Seaweed Blockchain Traceability Platform
31.01.	BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report

Zeit

Aktuelle Nachrichten

Seaweed grows for free in the ocean - and BPH Global is using it to extract silver; cobalt

BPH GLOBAL LTD: Exceptional silver and cobalt assays from seaweed

BPH GLOBAL LTD: Results of Meeting

BPH GLOBAL LTD: Deployment of Seaweed Blockchain Traceability Platform

31.01.

BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report

Zeit	Aktuelle Nachrichten
27.05.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024		Das Instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY wird ex Kapitalmassnahme gehandelt am 27.05.2024 The instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY is traded ex capital... ► Artikel lesen

Zeit

Aktuelle Nachrichten

27.05.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024

Zeit	Aktuelle Nachrichten
27.05.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024		Das Instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY wird ex Kapitalmassnahme gehandelt am 27.05.2024 The instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY is traded ex capital... ► Artikel lesen

Zeit

Aktuelle Nachrichten

27.05.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024

Zeit	Aktuelle Nachrichten
Fr	Gaslog Partners: Profit increase despite difficulties in the LNG market
Mo	GasLog collaborates with Propulsion Analytics for fleet Digital Engine Management platform development, enabled by Kongsberg Digital Vessel Insight
13.02.	GasLog Selects Propulsion Analytics for Fleet Digital Engine Management
13.02.	GasLog Partners LP - 6-K, Report of foreign issuer
19.12.24	Wärtsilä Gas Solutions service agreement to optimise liquefaction operations for five GasLog LNG carriers

Zeit

Aktuelle Nachrichten

Gaslog Partners: Profit increase despite difficulties in the LNG market

GasLog collaborates with Propulsion Analytics for fleet Digital Engine Management platform development, enabled by Kongsberg Digital Vessel Insight

13.02.

GasLog Selects Propulsion Analytics for Fleet Digital Engine Management

13.02.

GasLog Partners LP - 6-K, Report of foreign issuer

19.12.24

Wärtsilä Gas Solutions service agreement to optimise liquefaction operations for five GasLog LNG carriers

Zeit	Aktuelle Nachrichten
Do	Great Portland Ests. - GPE reports strong level of customer satisfaction
13.02.	Great Portland Estates completes four Piccadilly leasing deals
13.02.	Great Portland Estates inks four new fully managed leasing deals
13.02.	Great Portland Ests. - Further Fully Managed leasing success
06.02.	Great Portland Estates wins further lease agreements in London

Zeit

Aktuelle Nachrichten

Great Portland Ests. - GPE reports strong level of customer satisfaction

13.02.

Great Portland Estates completes four Piccadilly leasing deals

13.02.

Great Portland Estates inks four new fully managed leasing deals

13.02.

Great Portland Ests. - Further Fully Managed leasing success

06.02.

Great Portland Estates wins further lease agreements in London

Zeit	Aktuelle Nachrichten
Mi	NEXTCELL PHARMA AB: All Patients with Severe Virus-Induced Pneumonia Treated in the ProTrans V Study
30.01.	NextCell Pharma AB: NextCell Pharma publish Interim Report 1 2023/2024	NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 1 for the period September 1, 2024 - November 30, 2024. The report is available on the company's website: https://www.nextcellpharma.com/en/investorsfinancial-report.... ► Artikel lesen
17.12.24	NEXTCELL PHARMA AB: Long-term Effects with Repeated ProTrans Treatment After 6 Years
05.12.24	NEXTCELL PHARMA AB: NextCell Pharma changes Certified Adviser to Redeye AB
25.11.24	NEXTCELL PHARMA AB: QVance's Partnerships Driving Innovation in Advanced Therapies

Zeit

Aktuelle Nachrichten

NEXTCELL PHARMA AB: All Patients with Severe Virus-Induced Pneumonia Treated in the ProTrans V Study

30.01.

NextCell Pharma AB: NextCell Pharma publish Interim Report 1 2023/2024

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 1 for the period September 1, 2024 - November 30, 2024. The report is available on the company's website: https://www.nextcellpharma.com/en/investorsfinancial-report....
► Artikel lesen

17.12.24

NEXTCELL PHARMA AB: Long-term Effects with Repeated ProTrans Treatment After 6 Years

05.12.24

NEXTCELL PHARMA AB: NextCell Pharma changes Certified Adviser to Redeye AB

25.11.24

NEXTCELL PHARMA AB: QVance's Partnerships Driving Innovation in Advanced Therapies

Zeit	Aktuelle Nachrichten
Fr	NN Group outlines €1.6B free cash flow target for 2025, supported by strong solvency and capital actions
Do	NN Group NV reports FY results
Do	NN Group N.V.: NN Group reports continued strong business performance in 2024	Strong delivery on targets and attractive shareholder returns • Operating capital generation (OCG) for 2024 reached more than EUR 1.9 billion, reaching our 2025 target a year ahead of plan •... ► Artikel lesen
30.01.	NN Group N.V.: CEO Marcel Zuidam to leave Nationale-Nederlanden Bank	Marcel Zuidam, Chief Executive Officer (CEO) at Nationale-Nederlanden Bank (NN Bank) will step down as of 1 April 2025 to join Triodos Bank. Pieter Emmen, Chief Risk Officer of NN Bank, has been appointed... ► Artikel lesen
27.11.24	Domcura und Nationale-Nederlanden arbeiten zusammen	Der Assekuradeur Domcura und der niederländische Versicherer Nationale-Nederlanden gehen eine Zusammenarbeit ein. Künftig wird Nationale-Nederlanden einer der Risikoträger für Domcuras Einfamilien-... ► Artikel lesen

Zeit

Aktuelle Nachrichten

NN Group outlines €1.6B free cash flow target for 2025, supported by strong solvency and capital actions

NN Group NV reports FY results

NN Group N.V.: NN Group reports continued strong business performance in 2024

Strong delivery on targets and attractive shareholder returns • Operating capital generation (OCG) for 2024 reached more than EUR 1.9 billion, reaching our 2025 target a year ahead of plan •...
► Artikel lesen

30.01.

NN Group N.V.: CEO Marcel Zuidam to leave Nationale-Nederlanden Bank

Marcel Zuidam, Chief Executive Officer (CEO) at Nationale-Nederlanden Bank (NN Bank) will step down as of 1 April 2025 to join Triodos Bank. Pieter Emmen, Chief Risk Officer of NN Bank, has been appointed...
► Artikel lesen

27.11.24

Domcura und Nationale-Nederlanden arbeiten zusammen

Der Assekuradeur Domcura und der niederländische Versicherer Nationale-Nederlanden gehen eine Zusammenarbeit ein. Künftig wird Nationale-Nederlanden einer der Risikoträger für Domcuras Einfamilien-...
► Artikel lesen

Zeit	Aktuelle Nachrichten
11.02.	XFRA CAPITAL ADJUSTMENT INFORMATION - 11.02.2025		Das Instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY wird ex Kapitalmassnahme gehandelt am 11.02.2025 The instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY is traded ex capital... ► Artikel lesen
27.05.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024		Das Instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY wird ex Kapitalmassnahme gehandelt am 27.05.2024 The instrument 37P FR0010341032 FONCIERE INEA SA EO 14,39 EQUITY is traded ex capital... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11.02.

XFRA CAPITAL ADJUSTMENT INFORMATION - 11.02.2025

Das Instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY wird ex Kapitalmassnahme gehandelt am 11.02.2025 The instrument 5LN SE0010520155 ROLLING OPTICS HOLDING AB EQUITY is traded ex capital...
► Artikel lesen

27.05.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 27.05.2024

Zeit	Aktuelle Nachrichten
Do	SINTX Technologies Divests TA&T To Focus On Medical Devices
Do	SINTX Technologies divests technology assessment and transfer subsidiary
Do	SINTX Technologies, Inc.: SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market
Do	Sintx Technologies, Inc. - 8-K, Current Report
Mi	Sintx Technologies Stock Soars 62% On New Patent Issuance

Zeit

Aktuelle Nachrichten

SINTX Technologies Divests TA&T To Focus On Medical Devices

SINTX Technologies divests technology assessment and transfer subsidiary

SINTX Technologies, Inc.: SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Sintx Technologies, Inc. - 8-K, Current Report

Sintx Technologies Stock Soars 62% On New Patent Issuance

Unternehmen / Aktien	Kurs	%
BPH GLOBAL LTD	0,001	0,00 %
EUROPLASMA SA	0,011	-7,56 %
FONCIERE INEA SA	32,500	+2,52 %
GASLOG LTD PREF	22,700	0,00 %
GREAT PORTLAND ESTATES PLC	3,380	0,00 %
NEXTCELL PHARMA AB	0,262	+3,56 %
NN GROUP NV	46,690	-0,04 %
ROLLING OPTICS HOLDING AB	0,060	-0,66 %
SINTX TECHNOLOGIES INC	5,300	+10,42 %

Unternehmen / Aktien

Kurs

BPH GLOBAL LTD

0,001

0,00 %

EUROPLASMA SA

0,011

-7,56 %

FONCIERE INEA SA

32,500

+2,52 %

GASLOG LTD PREF